BeiGene initiates clinical trial of Tislelizumab with cancer patients

Drug Discovery |  News | 0 Comment | 31 Dec, 2018

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...Read more

Chugai obtains approval for Genomic Mutation Analysis Program

Drug Discovery |  News | 0 Comment | 27 Dec, 2018

Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...Read more

Cannabics files patent for personalized cannabimetic compositions modeling, production

Drug Discovery |  News | 0 Comment | 27 Dec, 2018

Cannabics Pharmaceuticals Inc., a world leader in personalized cannabinoid medicine focused on cancer and its side effec...Read more

I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2

Drug Discovery |  Company results | 0 Comment | 24 Dec, 2018

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...Read more

Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership

Drug Discovery |  News | 0 Comment | 20 Dec, 2018

Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...Read more

Lexicon Pharma announces positive topline clinical data for LX9211

Drug Discovery |  News | 0 Comment | 19 Dec, 2018

Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...Read more

Bridge Bio signs $40M license agreement with Daewoong Pharma

Drug Discovery |  News | 0 Comment | 19 Dec, 2018

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...Read more

FibroGen's roxadustat OK'd in China

Drug Discovery |  News | 0 Comment | 18 Dec, 2018

Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...Read more

Avacta, LG Chem Life Sciences to develop novel drugs for cancer, inflammation

Drug Discovery |  News | 0 Comment | 13 Dec, 2018

UK-based Avacta Group plc , the developer of Affimer biotherapeutics and reagents and Korea's LG Chem Life Science...Read more

Innovent declares positive result of IBI305, biosimilar to Avastin

Drug Discovery |  News | 0 Comment | 13 Dec, 2018

Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commerci...Read more

APLIDIN gets world-first approval for Multiple Myeloma

Drug Discovery |  News | 0 Comment | 11 Dec, 2018

Multiple myeloma patients from Australia will have world-first access to a new first-in-class drug developed to treat th...Read more

TauRx's LMTXs gets FDA Orphan-drug Designation

Drug Discovery |  News | 0 Comment | 10 Dec, 2018

TauRx, a leader in neurodegenerative disease research, announced that the US Food and Drug Administration (FDA) has gran...Read more

Diamyd Medical raises SEK 58.4 million through redemption of warrants

Drug Discovery |  News | 0 Comment | 06 Dec, 2018

Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...Read more

EC Approves Takeda’s ALUNBRIG for ALK+ Non-Small Cell Lung Cancer

Drug Discovery |  News | 0 Comment | 28 Nov, 2018

Takeda Pharmaceutical Company Limited announced that the European Commission (EC) granted marketing authorization for AL...Read more

HitGen, Biogen initiate drug discovery collaboration

Drug Discovery |  News | 0 Comment | 22 Nov, 2018

HitGen Ltd has announced that the company has entered into a drug discovery research collaboration with Biogen to identi...Read more

World’s first migraine-specific prevention treatment available in Singapore

Drug Discovery |  News | 0 Comment | 22 Nov, 2018

Singapore – Novartis announced that the Health Sciences Authority (HSA) has approved Aimovig (erenumab) ...Read more

OBI Pharma granted FDA ODD for OBI-888

Drug Discovery |  News | 0 Comment | 21 Nov, 2018

OBI Pharma, Inc., a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) h...Read more

Exscientia acquires Kinetic Discovery to build 'full stack' AI-driven drug discovery capabilities

Drug Discovery |  News | 0 Comment | 15 Nov, 2018

Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...Read more